James P. Mackin - Dec 3, 2025 Form 4 Insider Report for ARTIVION, INC. (AORT)

Signature
/s/ James P. Mackin
Stock symbol
AORT
Transactions as of
Dec 3, 2025
Transactions value $
-$489,820
Form type
4
Date filed
12/4/2025, 08:54 PM
Previous filing
Dec 3, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mackin James P President & CEO ARTIVION, INC., 1655 ROBERTS BLVD, NW, KENNESAW /s/ James P. Mackin 2025-12-04 0001408470

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AORT Common Stock Options Exercise $916K +30.9K +3.86% $29.62 832K Dec 3, 2025 Direct F1
transaction AORT Common Stock Sale -$1.41M -30.9K -3.72% $45.46 801K Dec 3, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AORT Stock Options (Right to buy) Options Exercise $0 -30.9K -100% $0.00 0 Dec 3, 2025 Common Stock 30.9K $29.62 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 2, 2025.
F2 Reflects weighted average price. Range of prices were between $45.09 to $45.91. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 5, 2020.